Century Therapeutics (IPSC) Net Cash Flow Growth (3y) (2023 - 2026)

Century Therapeutics (IPSC) Net Cash Flow Growth (3y) (2023 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	NCF Growth (3y) (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-50.33%
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	38.47%
4	NuCana	279.75 Bn	279.75 Bn	-	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	33.37%
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	-29.82%
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	-
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	-
10	Century Therapeutics	419.84 Mn	285.04 Mn	-	-85.51%

Download Data